The preliminary research of contrast-enhanced ultrasound in differential diagnosis of different molecular subtypes of breast cancer
Contrast-enhanced ultrasound
Progesterone receptor
DOI:
10.3760/cma.j.issn.1004-4477.2018.10.012
Publication Date:
2018-10-25
AUTHORS (5)
ABSTRACT
Objective
To explore the value of contrast-enhanced ultrasound (CEUS) in differential diagnosis different molecular subtypes breast cancer.
Methods
Sixty-two cases cancer patients with 62 lesions confirmed as by postoperative pathology were selected. Referencing St. Gallen standard and according to immunohistochemical markers estrogen receptor (ER), progesterone (PR) human epidermal growth factor 2 (Her-2) expression, all divided into Luminal epithelium A or B (Luminal A/B)subtype(26 ), Her-2 over-expression subtype(16 patients) triple negative (TN) subtype(20 patients). CEUS routine ultrasonography performed for before surgery, contrast enhancement patterns perfusion parameters recorded. Whether there was a difference between analyzed.
Results
①The pattern showed more radioactive gathering(76.9%, P 0.05).
Conclusions
Different have parameters, can provide valuable imaging information typing surgery.
Key words:
Contrast-enhanced ultrasound; Breast cancer; Molecular subtype
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....